Insulin Lispro
7 brands · 2 companies · product forms
Opportunity snapshot
Who competes here
Top companies by brand count — concentrated market · leader share 86%
Price room
max/min price ratio 7.43x across 7 trusted points (Rs 1525.2-11332.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Brands & products on the market
Sample of 4 live products for Insulin Lispro — each links to its own medicine page.
Why this score
Launch attractiveness
40% supply-gap(40) + 25% price-variation(100) + 20% low-competition(94) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.
Market saturation
2 canonical companies and 7 brands compete (saturation pegged at 30 companies / 150 brands).
Price room
max/min price ratio 7.43x across 7 trusted points (Rs 1525.2-11332.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Regulatory risk
No DRAP alerts on this molecule's brands.
Confidence
Reduced by: no ATC code.
Packaged brief for this strong opportunity?
Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.
See packaged reports All 3868 molecules